Ran Xu

机构：Wannan Medical College, Harvard University, Chinese Academy of Sciences, Anhui University of Traditional Chinese Medicine, Dana-Farber Cancer Institute, Tianjin Institute of Industrial Biotechnology, Chengdu University of Traditional Chinese Medicine, China Medical University · ORCID：0000-0002-7051-8564

发表论文 30 篇 · 总被引 356 次 · h-index 11

代表论文

• Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis (2024 · EClinicalMedicine · 被引 61)
• Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases (2021 · Frontiers in Cell and Developmental Biology · 被引 47)
• Effect of MicroRNA-126a-3p on Bone Marrow Mesenchymal Stem Cells Repairing Blood-brain Barrier and Nerve Injury after Intracerebral Hemorrhage (2020 · Journal of Stroke and Cerebrovascular Diseases · 被引 36)
• Prognostic value of tumor deposits in lymph node-negative gastric cancer: A propensity score matching study (2022 · European Journal of Surgical Oncology · 被引 21)
• Huangzhi Oral Liquid Prevents Arrhythmias by Upregulating Caspase-3 and Apoptosis Network Proteins in Myocardial Ischemia-Reperfusion Injury in Rats (2015 · Evidence-based Complementary and Alternative Medicine · 被引 18)
• Integrative single-cell and spatial transcriptomics analysis reveals MDK-NCL pathway’s role in shaping the immunosuppressive environment of lung adenocarcinoma (2025 · Frontiers in Immunology · 被引 16)